Skip to main content

The Adult Asthmatic

  • Chapter
  • First Online:
  • 2033 Accesses

Abstract

Asthma in adults is a clinical syndrome that is largely allergic in nature, which manifests reversible to partially reversible airway obstruction. Asthma is underdiagnosed and undertreated in the United States, especially in those who are >40 years of age or older. Despite the reduction in asthma mortality since 1996, morbidity and healthcare resource utilization associated with asthma continue to increase. Forty to sixty percent of asthma patients do not achieve asthma control, and the basics of asthma care are missing for large segments of the population, including African Americans, Native Indians, Hispanics, and Asians. The annual cost for asthma is nearly $15 billion with 80% of the direct costs directed at only 10–20% of asthmatic patients. The inability to bring about well-controlled asthma in every patient by applying the current NIH-NAEPP guidelines should draw attention to disease heterogeneity and the urgent need to reconsider old paradigms with new ideas.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

FEV1 :

Forced expiratory volume in the first second

AOA:

Adult onset asthma

LOA:

Late-onset asthma

GERD:

Gastroesophageal reflux disease

NAEPP-EPR3:

National Asthma Education and Prevention Program – Expert Panel Report 3

COPD:

Chronic obstructive pulmonary disease

CS:

Corticosteroid

ICS:

Inhaled corticosteroid

LABA:

Long-acting β-agonist

SABA:

Short-acting β-agonist

CDC:

Centers for disease control

HRT:

Hormone replacement therapy

CI:

Confidence interval

NSAID:

Nonsteroidal anti-inflammatory drug

COX:

Cyclooxygenase

LT:

Leukotriene

GOLD:

Global obstructive lung disease

cys-LT:

Cysteinyl leukotriene

BMI:

Body Mass Index

RANTES:

Regulated upon activation normal T-cell expressed and secreted

GWA:

Genome-wide association

NO:

Nitric oxide

NOS:

Nitric oxide synthase

AHR:

Airway hyperresponsiveness

FENO :

Fraction of exhaled nitric oxide

EBC:

Exhaled breath condensate

PEF:

Peak expiratory flow

LTRA:

Leukotriene receptor antagonist

PC20 :

The provocative concentration or dose of methacholine that causes a 20% decrease in baseline FEV1

FDA:

Food and drug administration

SARP:

Severe Asthma Research Program

ACRN:

Asthma Clinical Research Network

PPARγ:

Peroxisome proliferator-activated receptor-gamma

PDE4:

Phosphodiesterase 4

BDP:

Beclomethasonedipropionate

FP:

Fluticasone propionate

MDI:

Metered dose inhaler

DPI:

Dry powder inhaler

TNF:

Tumor necrosis factor

References

  1. Anderson, G. Endotyping Asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008;372:1107–19.

    Article  PubMed  Google Scholar 

  2. Moore WC, Meyers D.A, Wenzel SE, et al. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181:315–323.

    Article  PubMed  Google Scholar 

  3. Martinez, FD. The Origins of Asthma and Chronic Obstructive Pulmonary Disease in Early Life. Proc Am Thorac Soc 2009;6:272–277.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Martin RJ, Szefler SJ, King TS, et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 2007;119:73–80.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Braman, S. The Global Burden of Asthma. Chest 2006;130:4 S-12 S.

    Article  PubMed  Google Scholar 

  6. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010;376:803–13.

    Article  PubMed  Google Scholar 

  7. Buffels J, Degryse J., Heyrman J, et al. Office spirometry significantly improves early detection of COPD in general practice: The DIDASCO Study. Chest 2004;125:1394–99.

    Article  PubMed  Google Scholar 

  8. Abramson M, Matheson M., Wharton C, et al. Prevalence of respiratory symptoms related to chronic obstructive pulmonary disease and asthma among middle aged and older adults. Respirology 2002;7(4):325–31.

    Article  PubMed  Google Scholar 

  9. Soriano JB, Davis KJ, Coleman B, et al. The Proportional Venn Diagram of Obstructive Lung Disease: Two Approximations From the United States and the United Kingdom. Chest 2003;124:474–481.

    Article  PubMed  Google Scholar 

  10. Bochenska-Marciniak M, Kupczyk M, Gorski P, et al. Prevalence of atopy and the diagnostic value of skin prick tests in asthmatics over the age of 60. J Allergy Clin Immunol 2001;107(2): A862.

    Google Scholar 

  11. Mediaty A, Neuber K. Total and specific serum IgE decreases with age in patients with allergic rhinitis, asthma and insect allergy but not in patients with atopic dermatitis. Immunity & Ageing 2005;2:9–14.

    Article  CAS  Google Scholar 

  12. Huss K, Naumann PL, Mason PJ, et al. Asthma severity, atopic status, allergen exposure, and quality of life in elderly persons. Annals of Allergy, Asthma, & Immunonology 2001;86(5):524–530.

    Article  CAS  Google Scholar 

  13. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999;160:594–9.

    Article  CAS  PubMed  Google Scholar 

  14. Siroux V, Curt F., Oryszczyn MP, et al. Role of gender and hormone-related events on IgE, atopy, and eosinophils in the Epidemiological Study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy. J Allergy Clin Immunol 2004;114:491–98.

    Article  PubMed  Google Scholar 

  15. Barr RG, Wentowski CC, Grodstein F, et al. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med 2004;164:379–86.

    Article  PubMed  Google Scholar 

  16. Gakia E, Papatheodorou G., Ischakia E, et al. Leukotriene E4 in urine in patients with asthma and COPD – The effect of smoking habit. Respiratory Medicine 2007;101(4):826–832.

    Article  Google Scholar 

  17. Mastronarde JG, Anthonisen NR., Castro M, et al. Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma: The American Lung Association Asthma Clinical Research Centers. N Engl J Med 2009;360(15):1487–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gunnbjornsdottir MI, Omenaas E., Gislason T, et al. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J 2004;24:116–21.

    Article  CAS  PubMed  Google Scholar 

  19. Beuther DA, Weiss ST, Sutherland ER. Obesity and Asthma. Am J Respir Crit Care Med 2006;174:112–119.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hizawa N, Yamaguchi E, Konno S, et al. A functional polymorphism in the RANTES gene promotor is associated with the development of late-onset asthma. Am J Respir Crit Care Med 2002;166:686–690.

    Article  PubMed  Google Scholar 

  21. van Diemen CC, Postma DS, Vonk JM, et al. A Disintegrin and Metalloprotease 33 Polymorphisms and Lung Function Decline in the General Population. Am J Respir Crit Care Med 2005;172:329–333.

    Article  PubMed  Google Scholar 

  22. Raby BA, Van SK, Celedon JC, et al. CAMP Research Group. Paternal history of asthma and airway responsiveness in children with asthma. Am J Respir Crit Care Med 2005;172:552–558.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Melen E, Bruce S, Doekes G, et al. Haplotypes of G protein-coupled receptor 154 are associated with childhood allergy and asthma. Am J Respir Crit Care Med 2005;171:1089–1095.

    Article  PubMed  Google Scholar 

  24. Litonjua AA, Lasky-Su J, Schneiter K, et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008;178:688–694.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sohn MH, Lee JH, Kim KW, et al. Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med 2009;179:449–456.

    Article  CAS  PubMed  Google Scholar 

  26. Smit LA, Siroux V, Bouzigon E, et al. CD14 and toll-like receptor gene polymorphisms, country ­living, and asthma in adults. Am J Respir Crit Care Med 2009;179:363–368.

    Article  CAS  PubMed  Google Scholar 

  27. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009;41:342–347.

    Article  CAS  PubMed  Google Scholar 

  28. Prefontaine D, Lajoie-Kadoch S, Foley S, et al. Increased expression of IL-33 in severe asthma: ­evidence of expression by airway smooth muscle cells. J Immunol 2009;183:5094–5103.

    Article  CAS  PubMed  Google Scholar 

  29. Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled cross-over trial. Lancet 2004;364:1505–12.

    Article  CAS  PubMed  Google Scholar 

  30. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004;113:101–8.

    Article  PubMed  Google Scholar 

  31. Schneider A, Tilemann L, Schermer T, et al. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement – results of a prospective diagnostic study. Respiratory Research 2009;10:15–25.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 2007;176:238–242.

    Article  CAS  PubMed  Google Scholar 

  33. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma: Full Report. Bethesda, MD: National Institutes of Health, US Dept of Health and Human Services, National Heart, Lung, and Blood Institute., 2007 (http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm.).

  34. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma. N Engl J Med 2010;363:1715–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Szefler SJ, Martin RJ, King TS, et al., Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109(3):410–8.

    Article  CAS  PubMed  Google Scholar 

  36. Rabe KF, Pizzichini E, Stallberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006;129:246–256.

    Article  CAS  PubMed  Google Scholar 

  37. Salpeter SR, Ormiston TM, Salpeter EE. Meta-analysis: respiratory tolerance to regular β2 -agonist use in patients with asthma. Ann Intern Med 2004;140:802–13.

    Article  PubMed  Google Scholar 

  38. Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001;285:2583–93.

    Article  CAS  PubMed  Google Scholar 

  39. Nelson HS, W.S., Bleecker ER, et al. and the SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol. Chest 2006;129:15–26.

    Google Scholar 

  40. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108(2):184–190.

    Article  CAS  PubMed  Google Scholar 

  41. Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003;58(3):204–210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 2003;327(7420):891–896.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Sims EJ, Jackson CM, Lipworth BJ. Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype. Br J Clin Pharmacol 2003;56:104–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973–984.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985–993.

    Article  CAS  PubMed  Google Scholar 

  46. Denning DW, O’Driscoll B, Powell G, et al. Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization: The Fungal Asthma Sensitization Trial (FAST) Study. Am J Respir Crit Care Med 2009;179:11–18.

    Article  CAS  PubMed  Google Scholar 

  47. Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin Targets Neutrophilic Airway Inflammation in Refractory Asthma. Am J Respir Crit Care Med 2008;177:148–155.

    Article  CAS  PubMed  Google Scholar 

  48. Sutherland ER, King TS, Icitovic N, et al. for the National Heart, Lung and Blood Institute’s Asthma Clinical Research Network. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 2010;126:747–53.

    Article  CAS  Google Scholar 

  49. Daoud A, Gloria CJ, Taningco G, et al. Minocycline treatment results in reduced oral steroid requirements in adult asthma. Allergy Asthma Proc 2008;29(3):286–94.

    Article  CAS  PubMed  Google Scholar 

  50. Castro M, Rubin AS, Laviolette M, et al. AIR2 Trial Study Group. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010;181(2):116–24.

    Article  Google Scholar 

  51. Miller JD, Cox G, Vincic L, et al. A Prospective Feasibility Study of Bronchial Thermoplasty in the Human Airway. Chest 2005;127:1999–2006.

    Article  PubMed  Google Scholar 

  52. Cox G, Thomson NC, Rubin AS, et al. AIR Trial Study Group. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007;356(13):1327–37.

    Article  CAS  PubMed  Google Scholar 

  53. Pavord ID, Cox G, Thomson NC, et al. RISA Trial Study Group. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007;176(12):1185–91.

    Article  CAS  Google Scholar 

  54. Cox MB, Laviolette M, Rubin A, et al. 5-year Safety of Bronchial Thermoplasty Demonstrated in Patients with Moderate to Severe Asthma: Asthma Intervention Research (AIR) Trial. Am J Respir Crit Care Med 2010;181:A6839.

    Google Scholar 

  55. Barnes, P. New therapies for asthma: is there any progress? Trends in Pharmacological Sciences 2010;31(7):335–343.

    Article  CAS  PubMed  Google Scholar 

  56. Sutherland ER, Goleva E, Jackson LP, et al. Vitamin D Levels, Lung Function, and Steroid Response in Adult Asthma. Am J Respir Crit Care Med 2010;181:699–704.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Grootendorst DC, Gauw S, Verhoosel RM, et al. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax 2007;62:1081–1087.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Lu S, Liu N, Dass SB, et al. Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma. Respiratory Medicine 2009;103:342–347.

    Article  PubMed  Google Scholar 

  59. Liao JK, LaufsU. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89–118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Alexeeff SE, Litonjua A, Sparrow D, et al. Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med 2007;176:742–747.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Blamoun AI, Batty G, DeBari VA, et al. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract 2008;62(9):1373–8.

    Article  CAS  PubMed  Google Scholar 

  62. Soyseth V, Brekke P, Smith P, et al. Statin use is associated with reduced mortality in COPD. Eur Respir J 2007;29(2):279–83.

    Article  CAS  PubMed  Google Scholar 

  63. Hothersall EJ, Chaudhuri R, McSharry C, et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax 2008;63:1070–1075.

    Article  CAS  PubMed  Google Scholar 

  64. Menzies D, Nair A, Meldrum KT, et al. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 2007;119:328–335.

    Article  CAS  PubMed  Google Scholar 

  65. Cowan DC, Cowan JO, Palmay R, et al. Simvastatin in the treatment of asthma: lack of steroid-sparing effect. Thorax 2010;65:891–896.

    Article  PubMed  Google Scholar 

  66. Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, et al. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol 2010;126:754–62.

    Article  CAS  PubMed  Google Scholar 

  67. Drazen JM, Boccuzzi S, Wogen J, et al. Adherence to prescribed treatment for asthma. Am J Respir Crit Care Med 2000;161:A402.

    Google Scholar 

  68. Sundberg R, Toren K, Franklin KA, et al. Asthma in men and women: Treatment adherence, anxiety, and quality of sleep. Respiratory Medicine 2010;104:337–344.

    Article  PubMed  Google Scholar 

  69. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31(1):143–178.

    Article  PubMed  Google Scholar 

  70. Wenzel SE, Fahy JV, Irvin C, et al. Proceedings of the ATS workshop on refractory asthma current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162:2341–2351.

    Article  PubMed  Google Scholar 

  71. Barnes P. Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Clin Exp Allergy 2009;39:1145–1151.

    Article  PubMed  Google Scholar 

  72. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001–1008.

    Article  PubMed  Google Scholar 

  73. Simpson JL, Scott R, Boyle MJ, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006;11:54–61.

    Article  PubMed  Google Scholar 

  74. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009;180:388–395.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Melgert BN, Ray A, Hylkema MN, et al. Are there reasons why adult asthma is more common in females? Curr Allergy Asthma Rep 2007;7:143–150.

    Article  PubMed  Google Scholar 

  76. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006;368:780–793.

    Article  PubMed  Google Scholar 

  77. Schleimer RP, Kato A, Kern R, et al. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 2007;120:1279–1284.

    Article  PubMed  Google Scholar 

  78. Sciurba F. Physiologic similarities and differences between COPD and asthma. Chest 2004;126:117S–124S.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amir A. Zeki MD, MAS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Zeki, A.A., Kenyon, N.J., Yoneda, K., Louie, S. (2012). The Adult Asthmatic. In: Gershwin, M., Albertson, T. (eds) Bronchial Asthma. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6836-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6836-4_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-6835-7

  • Online ISBN: 978-1-4419-6836-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics